Values and Preferences in Clinical Practice Guidelines Gordon Guyatt Clarity Research Group McMaster University.

Slides:



Advertisements
Similar presentations
Summary Prepared by Melvyn Rubenfire, MD
Advertisements

©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
JNC 8 Guidelines….
EPECEPECEPECEPEC EPECEPECEPECEPEC Goals of Care Goals of Care Module 7 The Project to Educate Physicians on End-of-life Care Supported by the American.
1 Sixty-Four-Slice Computed Tomography of the Coronary Arteries: Cost-Effectiveness Analysis of Patients Presenting to the ED with Low Risk Chest Pain.
Improving The Clinical Care of Children and Adolescents With Mild Traumatic Brain Injury Madeline Joseph, MD, FACEP, FAAP Professor of Emergency Medicine.
Stroke Mark Sudlow Consultant and Senior Lecturer
Researching Patient & Clinician Relevant Outcomes Laura Sheard, PhD.
Decision Analysis Prof. Carl Thompson
Prophylaxis of Venous Thromboembolism
Decision Analysis. What is decision analysis? Based on expected utility theory Based on expected utility theory Used in conditions of uncertainty Used.
POC INR Testing Rural and Remote Session 2015 CADTH SYMPOSIUM Janice Mann MD Knowledge Mobilization, CADTH.
Maine Emergency Medical Services Department of Public Safety Maine Heartsafe Communities Welcome.
Stroke Awareness.
ACEP Clinical Policy: Adult Headache Patients. Ponte Vedra Beach, FL June 24, Clinical Decision Making in Emergency Medicine Ponte Vedra Beach,
EPECEPECEPECEPEC EPECEPECEPECEPEC Advance Care Planning Advance Care Planning Module 1 The Project to Educate Physicians on End-of-life Care Supported.
INTRODUCTION HINF 371 Medical Methodologies Session 1.
From Sick Note to Fit Note
Do not be a victim. What is a Stroke A stroke is the result of injury to brain tissue from lack of oxygen A stroke occurs when blood flow to the cells.
Angina and MI.
1 Measuring Patients’ Experience of Hospital Care Angela Coulter Picker Institute Europe
What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Critical Appraisal of Clinical Practice Guidelines
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
Evidence Based Medicine and Medical Decision Making Iztok Hozo, Professor of Mathematics Indiana University Northwest European School of Oncology How to.
Knee Replacement Surgery Evaluating Rehabilitation Management Strategies Dr Marlene Fransen.
Talking to Your Patients about Advance Directives Stephanie Reynolds, ACHPN Dawn Kilkenny, LCSW Palliative Care Department (Pager)
Dr.F Eslamipour DDS.MS Orthodontist Associated professor Department of Oral Public Health Isfahan University of Medical Science.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Which Disease is Worse? Angina, Stroke, or Heart Attack?
Research Techniques Made Simple: Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE Mayra Buainain de.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
ST CATHERINE’S HOSPICE Primary thromboprophylaxis in advanced disease MJ Johnson.
Plan GRADE backgroundGRADE background confidence in estimates (quality of evidence)confidence in estimates (quality of evidence) evidence profilesevidence.
Vanderbilt Sports Medicine Chapter 5: Therapy, Part 2 Thomas F. Byars Evidence-Based Medicine How to Practice and Teach EBM.
Two questions in grading recommendations Are you sure?Are you sure? –Yes: Grade 1 –No: Grade 2 What is the methodological quality of the underlying evidenceWhat.
Asthma Management and the Allergist: Better Outcomes at Lower Cost.
Evidence-based medicine
CAT 5: How to Read an Article about a Systematic Review Maribeth Chitkara, MD Rachel Boykan, MD.
Stroke is a Medical Emergency. Face Arm Speech Test Helps public recognise symptoms of stroke; Can they smile? Does one side droop? Can they lift both.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Decision Analytic Approaches for Evidence-Based Practice M8120 Fall 2001 Suzanne Bakken, RN, DNSc, FAAN School of Nursing & Department of Medical Informatics.
Matching Analyses to Decisions: Can we Ever Make Economic Evaluations Generalisable Across Jurisdictions? Mark Sculpher Mike Drummond Centre for Health.
Developing evidence-based guidelines at WHO. Evidence-based guidelines at WHO | January 17, |2 |
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
EBM --- Journal Reading Presenter :葉麗雯 Date : 2005/10/27.
What Is a Stroke? Stroke is the blocking or bursting of a blood vessel that supplies blood to the brain. During a stroke a portion of the.
GDG Meeting Wednesday November 9, :30 – 11:30 am.
Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
Clinical Practice Guidelines: Can we fix Babel? Eddy Lang Department Chair, Emergency Alberta Health Services Associate Professor University of Calgary.
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Approach to guideline development
Atrial fibrillation J Heinsimer MD.
Why this talk? you will be seeing a lot of GRADE
Patient Focused Drug Development An FDA Perspective
Conflicts of interest Major role in development of GRADE
Antithrombotic Therapy in Peripheral Artery Disease
Cardio- vascular diseases
EAST GRADE Course 2019 PICO Question Formulation
How to Recognize the Signs of Heart Attack and Stroke
Presentation transcript:

Values and Preferences in Clinical Practice Guidelines Gordon Guyatt Clarity Research Group McMaster University

Plan  what is the problem?  whose values and preferences?  how can we find out about values and preferences?  applying best estimates of V and P

What is the problem?  almost all decisions/recommendations involve tradeoffs  benefits versus harms, burden, costs  antithrombotic therapy  thrombosis reduction vs bleeding, burden, costs  tradeoffs require V and P judgments  value reducing MI, stroke, DVT vs bleed and burden

What are values and preferences? judgments of disutility judgments of disutility ▪ burden or negative outcomes associated with a particular health state “a broad term that includes patient perspectives, beliefs, expectations, and goals for their health and life, including the process that patients go through in weighing the potential benefits, harms, costs, and burdens associated with different treatments or disease management options” “a broad term that includes patient perspectives, beliefs, expectations, and goals for their health and life, including the process that patients go through in weighing the potential benefits, harms, costs, and burdens associated with different treatments or disease management options”

What have guideline panels done in the past ?  ignored  unaware that making V and P judgments  implicit, unconscious V and P of panelists  remains least understood, most poorly practiced area of guideline development

Whose values and preferences?  guideline panel members  health care providers  policy makers  subjects of the guideline  patients  general public

How to determine patient values and preferences?  systematic review of patient V and P  use guideline panel members  act as proxies for their patients’ V and P  patients on panel  collect own values and preferences data

Systematic review  comprehensive search  48 studies  16 a fib, 10 stroke or MI, 5 VTE, 17 burden  higher disutility on stroke than gastrointestinal bleed and much greater disutility on stroke than on treatment burden  example of the relative value of health states:  a reasonable trade-off between nonfatal stroke and bleeds is a ratio of disutility of 2.1 to 3.1

Systematic review, continued  little consistency in health state preferences  contributing factors?  measurement methods (understanding)  prior experience with the treatment  description of event  prior experience with adverse event, example stroke  cause of the adverse event: treatment-related versus “natural”; higher value avoiding treatment-induced events than avoiding events treatment prevents  age, sex

Using systematic review results  systematic review results require interpretation  how should guideline panel proceed?  systematic V and P rating exercise  ACCP  consider systematic review  make ratings for typical patients  rate scenarios, time frame of one year

Venous limb gangrene scenario Physical You suddenly develop severe pain in the leg where you have your blood clot and your toes start to turn black. You suddenly develop severe pain in the leg where you have your blood clot and your toes start to turn black. Treatment You have to stay in hospital. You have to stay in hospital. You stop taking warfarin. You stop taking warfarin. The swelling in your leg gets worse and the pain is severe. The swelling in your leg gets worse and the pain is severe. You receive a new blood thinner through your intra-venous line You receive a new blood thinner through your intra-venous line Recovery After a few weeks, your toes return to normal. After a few weeks, your toes return to normal.

13  Dead  Full Health Feeling thermometer: Venous limb gangrene  Minimum  Maximum  Mean

Disutility with stroke in a child Physical Symptoms  Your child suddenly becomes unresponsive  Your child is unable to move one arm and one leg  Your child cannot speak to you Mental Symptoms  Your child is irritable and upset  You find it difficult to console your child  Family and friends find the diagnosis difficult to accept Pain  Your child has a headache for a number of days Recovery  Your child’s stay in hospital is prolonged  Your child recovers some function, including speech and movement slowly over weeks to months  Your child complains of tiredness for months  Your child needs help to attend normal school  Your child has multiple hospital visits for physiotherapy and rehabilitation  You must alter your hopes and dreams for your child’s future Further Risk  You are told your child is not at risk of further strokes,  You find your child’s ongoing limitations very hard to accept 14

15  Dead  Full Health Feeling thermometer: Major stroke in a child  Minimum  Maximum  Mean

Disutility with a gastrointestinal bleed Symptoms  You feel nauseated and unwell for two days, and then suddenly you vomit blood and feel faint. Diagnostic tests and treatment  You are taken by ambulance to a busy emergency department.  An intravenous catheter is placed and a catheter is placed through your nose into your stomach to help drain the blood  You receive blood transfusions to replace the blood you lost  You are admitted to hospital  A doctor puts a tube down your throat into your stomach to see where you are bleeding from and to provide treatment  You receive sedation by intravenous to ease the discomfort of the test  You do not require an operation to stop the bleeding  You must stop taking your blood thinner; stopping the blood thinner puts you at risk of developing a new blood clot. Recovery  You stay in the hospital for a few days  You feel much better at the end of your hospital stay  You need to take pills for the next six month to prevent further bleeding  After that, you are back to normal  About 2 weeks after your bleeding you restart your blood thinning therapy – you worry every day about more bleeding for the first month after restarting  After that, your worry gradually decreases 16

17  Dead  Full Health Feeling thermometer: Gastrointestinal bleed  Minimum  Maximum  Mean

Key decisions  myocardial infarction = pulmonary embolus = venous thrombosis = gastrointestinal bleed  stroke = 3 bleeds (and thus three of any other major event)

What lowers strength of recommendation?  strong recommendation  confident more good than harm  almost all informed patient make same choice  tight balance  uncertainty about typical V and P  uncertainty about variability in V and P  V and P highly variable

 Strong recommendation for warfarin

Alternatives: experience of clinicians in shared decision making

Patients on panel  often advocated  may be useful in issues overlooked  no guarantee reflects typical V and P

 establish that everyone agrees with evidence summary  clarify values and preferences  Review evidence about patient V and P

Conclusions  value and preference judgments ubiquitous  panels MUST make judgments explicit  quantitation desirable  values those who bear consequences  weak recommendation more likely  close trade-off  uncertainty in typical V and P  highly variable V and P

Conclusions  systematic review of V and P – routine  still need panel input  study results require interpretation  results likely incomplete  structured elicitation of panel V and P  patients on panel – questionable  expert panel shared decision-making